Paper

0

Document

Download

Flag content

0

Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study

Biomedical Engineering

Show More

Authors

Masaru Seguchi,Alp Aytekin

Erion Xhepa,Michael Haude,Adrian Włodarczak,René Schaaf,Jan Torzewski,Bert Ferdinande,Javier Escaned,Juan Iglesias,Johan Bennett,Eugene Blackstone,Ralph Töelg,Marcus Wiemer,Göran Olivecrona,Paul Vermeersch,Ron Waksman

+15 authors

,Héctor García‐García

Journal

EuroIntervention

Published

Sep 1, 2024

DOI

10.4244/eij-d-24-00055

Show more

Save

Tip

Document

Download

Flag content

0

Tip

Save

Document

Download

Flag content

Abstract

The 12-month outcomes of BIOMAG-I - the first-in-human study investigating the third-generation drug-eluting resorbable magnesium scaffold (DREAMS 3G) - showed promising results regarding clinical outcomes and late lumen loss.

Paper PDF

This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.